# EDGAR Filing Document

**Accession Number:** 0001640266
**File Stem:** 9999999995-25-003446
**Filing Date:** 2025-12
**Character Count:** 1290
**Document Hash:** 1efd5e459d38cd29f379b6db1f62a8f1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999995-25-003446.hdr.sgml**: 20251202

**ACCESSION NUMBER**: 9999999995-25-003446

**CONFORMED SUBMISSION TYPE**: EFFECT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251201

**DATE AS OF CHANGE**: 20251202

**EFFECTIVENESS DATE**: 20251201

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Voyager Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001640266
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** EFFECT
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-291418
- **FILM NUMBER:** 251541496

**BUSINESS ADDRESS:**
- **STREET 1:** 75 HAYDEN AVENUE
- **CITY:** LEXINGTON
- **STATE:** MA
- **ZIP:** 02421
- **BUSINESS PHONE:** 857-259-5340

**MAIL ADDRESS:**
- **STREET 1:** 75 HAYDEN AVENUE
- **CITY:** LEXINGTON
- **STATE:** MA
- **ZIP:** 02421

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Effectiveness

**Date:** December 1, 2025

**Time:** 16:30:00

**Form Type:** S-3

---

**CIK:** 0001640266

**Company Name:** Voyager Therapeutics, Inc.

**File Number:** 333-291418